杭州泰格医药科技股份有限公司（“杭州泰格医药”，A股代码：300347，H股代码：03347）于2026年2月3日公布了截至2026年1月31日的股份变动月报表，报告显示公司股本状况整体保持稳定。
公司注册股本方面，A股注册股数为737,901,250股，H股注册股数为123,124,800股，两者在本月均无增减，总注册股本维持在861,026,050股。已发行股份和库存股数量同样未发生变动，其中A股已发行732,017,470股，另有5,883,780股A股作为库存股；H股已发行123,124,800股，无库存股。
公告未披露任何新增发行、购回或注销情况，亦无涉及股份期权、可换股票据或权证等进一步变动信息。公司在报告中确认满足香港联交所关于公众持股量的相关要求，后续将持续依法合规披露公司股份变动情况。
该公告由公司董事叶小平签署并发布。公司表示，未来将严格遵守香港联交所《上市规则》以及相关法律法规的规定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.